Juvenile chronic myelogenous leukemia multilineage CD34+ cells: aberrant growth and differentiation properties

Stem Cells
M H FreedmanJ Squire

Abstract

Juvenile chronic myelogenous leukemia (JCML) is a hematologic malignancy of monocyte-macrophage lineage in which leukemic progression is mediated in an autocrine manner by tumor necrosis factor (TNF-alpha), GM-CSF and possibly other growth factors. Cytogenetic data showing involvement of both erythroid and monocyte-macrophage lineages in the JCML leukemic clone, as well as an observed episode of B-lineage lymphoid blast crisis in JCML, has strengthened the thesis for a lympho-hematopoietic pluripotent stem cell origin for the disorder. To study this further, JCML CD34+ cells from bone marrow (BM) or spleen from six newly diagnosed patients were isolated and cultured in clonogenic assays with combinations of recombinant cytokines. Compared to control CD34+ cells, JCML cells from all patients showed an aberrant growth pattern restricted almost exclusively to the monocyte-macrophage lineage. Most of the clonogenic activity was seen in a subsorted population of CD34+, HLA-Dr- cells. Additionally, an exaggerated growth response to minute doses of GM-CSF that had no effect on control cells was observed with JCML CD34+ cells. Recloning ("self-renewal") of JCML CD34+ cells was also strongly promoted by GM-CSF. JCML colonies also formed...Continue Reading

References

Jan 1, 1977·Journal of Immunological Methods·S B TuckerR E Jordon
Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C M BaumB Peault
Nov 1, 1991·The Journal of Experimental Medicine·B PéaultA Tsukamoto
Jan 1, 1990·The American Journal of Pediatric Hematology/oncology·M A KirbyM H Freedman
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H J SutherlandC J Eaves
Dec 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H S ChanM H Freedman
Mar 1, 1988·The Journal of Clinical Investigation·R J BerensonI D Bernstein
Jan 1, 1988·The American Journal of Pediatric Hematology/oncology·M H FreedmanH S Chan
Jul 11, 1986·Journal of Immunological Methods·R J BerensonD Kalamasz
Oct 1, 1988·The Journal of Clinical Investigation·G C BagbyE McCall
May 1, 1993·The Journal of Experimental Medicine·W CraigP M Lansdorp

❮ Previous
Next ❯

Citations

Dec 22, 1999·Journal of Pediatric Hematology/oncology·H C RossbachJ L Barbosa
Mar 20, 2009·PLoS Biology·Amit J SabnisBenjamin S Braun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.